TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
Renapharma AB
Closing information (x1000 SEK)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
30,205
|
30,159
|
23,103 |
Financial expenses |
77
|
32
|
110 |
Earnings before taxes |
6,603
|
7,374
|
7,962 |
EBITDA |
7,171
|
7,899
|
9,218 |
Total assets |
44,263
|
37,137
|
25,991 |
Current assets |
21,686
|
19,441
|
9,727 |
Current liabilities |
9,664
|
7,708
|
2,098 |
Equity capital |
26,497
|
19,895
|
12,520 |
- share capital |
100
![]() |
100
![]() |
100 |
Employees (average) |
4
![]() |
4
|
3 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
59.9%
|
53.6%
|
48.2% |
Turnover per employee |
7,551
|
7,540
|
7,701 |
Profit as a percentage of turnover |
21.9%
|
24.5%
|
34.5% |
Return on assets (ROA) |
15.1%
|
19.9%
|
31.1% |
Current ratio |
224.4%
|
252.2%
|
463.6% |
Return on equity (ROE) |
24.9%
|
37.1%
|
63.6% |
Change turnover |
46
|
7,056
|
5,878 |
Change turnover % |
0%
|
31%
|
34% |
Chg. No. of employees |
0
|
1
|
-1 |
Chg. No. of employees % |
0%
|
33%
|
-25% |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.